Home » FDA Warns Abiomed on Unauthorized Heart Pump Marketing
FDA Warns Abiomed on Unauthorized Heart Pump Marketing
Shares in Abiomed fell Tuesday after the company received a letter from the FDA accusing the company of marketing one of its Impella heart pumps without marketing clearance.
Mass High Tech
Mass High Tech
Upcoming Events
-
07May
-
14May
-
30May